Sources | Names Used |
---|---|
GDSC1000 | KIN001-270 |
PharmacoGx | KIN001-270 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADRB3 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |
mRNA | ILF3 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | C1orf109 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | HS3ST4 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-05 |
mRNA | CUX2 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | ZFP69B | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | WDR33 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | PRDM15 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | SLC25A19 | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-06 |
mRNA | IGLL5 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |